US Broker Ratings

Benitec Biopharma Inc. (BNTC) Stock Analysis: Potential 91.57% Upside with Strong Buy Ratings

Benitec Biopharma Inc. (NASDAQ: BNTC), a clinical-stage biotechnology company, is making waves in the healthcare sector with its innovative approach to gene therapy. Headquartered in Hayward,..

Heron Therapeutics, Inc. (HRTX) Stock Analysis: A Potential 251% Upside with Promising Analyst Ratings

Heron Therapeutics, Inc. (HRTX) presents an intriguing opportunity for investors focused on the biotechnology sector. With a market capitalization of $234.7 million, Heron is a commercial-stage..

Sprout Social, Inc (SPT) Stock Analysis: Assessing a 58% Potential Upside in a Competitive Market

Sprout Social, Inc (NASDAQ: SPT) stands as a formidable player in the technology sector, specializing in software applications for social media management. Headquartered in Chicago, Illinois,..

Fulcrum Therapeutics, Inc. (FULC) Stock Analysis: Exploring a Promising 58% Upside and Biotech Innovations

Fulcrum Therapeutics, Inc. (NASDAQ: FULC), a clinical-stage biopharmaceutical company, has been drawing attention in the biotechnology sector with its innovative approach to tackling genetically defined diseases...

Zhengye Biotechnology Holding L (ZYBT): Investor Outlook Amidst a Challenging Year

Zhengye Biotechnology Holding L (NASDAQ: ZYBT) sits at the intersection of healthcare innovation and agricultural needs, focusing on the production and sale of veterinary vaccines. Based..

National Research Corporation (NRC) Stock Analysis: A Healthcare Insights Leader with Robust ROE

National Research Corporation (NRC) stands at the intersection of healthcare and technology, providing critical analytics and insights that empower healthcare organizations to enhance both patient and..

Neuronetics, Inc. (STIM) Stock Analysis: Exploring a 357.75% Potential Upside in the Healthcare Sector

Neuronetics, Inc. (NASDAQ: STIM), a prominent player in the medical devices industry, is capturing the attention of investors with its significant growth potential. Headquartered in Malvern,..

Arcturus Therapeutics Holdings (ARCT) Stock Analysis: Unveiling a 446% Potential Upside

Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT) stands at the forefront of biotechnology innovation, focused on developing mRNA-based therapeutic solutions for infectious diseases and rare genetic disorders...

Varex Imaging Corporation (VREX) Stock Analysis: Exploring a 41.68% Potential Upside in the Healthcare Sector

Varex Imaging Corporation (NASDAQ: VREX), a key player in the healthcare sector, primarily focuses on the design and manufacture of X-ray imaging components. Operating through two..

XOMA Royalty Corporation (XOMA) Stock Analysis: Unveiling a 148% Upside Potential

XOMA Royalty Corporation (NASDAQ: XOMA) offers an intriguing prospect for investors looking to tap into the biotechnology sector’s lucrative potential. As a biotech royalty aggregator, XOMA..

Outset Medical, Inc. (OM) Stock Analysis: Evaluating the 302% Upside Potential

Outset Medical, Inc. (NASDAQ: OM), a pioneer in the healthcare sector with its innovative hemodialysis solutions, presents a compelling investment opportunity, especially for risk-tolerant investors intrigued..

Viemed Healthcare, Inc. (VMD) Stock Analysis: Exploring a 78% Upside Potential for Investors

Viemed Healthcare, Inc. (NASDAQ: VMD) is a noteworthy player in the healthcare sector, specifically within the medical devices industry. Headquartered in Lafayette, Louisiana, Viemed specializes in..

NANO-X IMAGING LTD (NNOX) Stock Report: Exploring the 173% Potential Upside

Nano-X Imaging Ltd (NASDAQ: NNOX), a healthcare disruptor from Israel, is making waves in the medical devices industry with its cutting-edge digital X-ray technology. With a..

Alpha Teknova, Inc. (TKNO) Stock Analysis: A Promising 118.98% Potential Upside Awaits Investors

Alpha Teknova, Inc. (TKNO), a key player in the healthcare sector, has been capturing investor attention with its innovative contributions to drug manufacturing, especially in the..

Cytek Biosciences, Inc. (CTKB): Investor Outlook on a Potential 13.41% Upside

Cytek Biosciences, Inc. (NASDAQ: CTKB) is making waves in the healthcare sector, specifically within the medical devices industry. With a market capitalization of $648.27 million, this..

Cidara Therapeutics, Inc. (CDTX) Stock Analysis: Navigating Growth in the Biotech Sector with a 0.29% Potential Upside

Cidara Therapeutics, Inc. (NASDAQ: CDTX) stands at the forefront of the biotechnology sector with a focus on developing innovative therapies for critical medical conditions, notably invasive..

Erasca, Inc. (ERAS) Stock Analysis: Exploring a Potential 49% Upside in Precision Oncology

Erasca, Inc. (ERAS) has caught the attention of investors with its promising foray into the precision oncology sector. The San Diego-based biotechnology firm is at the..

Rigel Pharmaceuticals, Inc. (RIGL) Stock Analysis: A 14.70% Upside Potential Awaits Investors

Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL), a notable player in the biotechnology sector, is making waves with its promising pipeline and strong financial metrics. Headquartered in South..

Chevron Corporation (CVX) Stock Analysis: Exploring a 14.51% Upside Potential Amid Volatile Markets

As an energy giant with a market capitalization of $303.23 billion, Chevron Corporation (NYSE: CVX) remains a formidable player in the integrated oil and gas industry...

Healthcare Services Group, Inc. (HCSG) Stock Analysis: Unlocking a 9.25% Potential Upside

Healthcare Services Group, Inc. (NASDAQ: HCSG) stands out in the competitive healthcare sector with its specialized focus on providing essential services to medical care facilities. With..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds